Literature DB >> 15020532

Inflammatory mediators in chronic heart failure: an overview.

Stefan D Anker1, Stephan von Haehling.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15020532      PMCID: PMC1768165          DOI: 10.1136/hrt.2002.007005

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  28 in total

Review 1.  Inflammatory mediators and the failing heart: past, present, and the foreseeable future.

Authors:  Douglas L Mann
Journal:  Circ Res       Date:  2002-11-29       Impact factor: 17.367

Review 2.  Tumour necrosis factor in chronic heart failure: a peripheral view on pathogenesis, clinical manifestations and therapeutic implications.

Authors:  A P Bolger; S D Anker
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

3.  How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH.

Authors:  Stefan D Anker; Andrew J S Coats
Journal:  Int J Cardiol       Date:  2002-12       Impact factor: 4.164

4.  C-Reactive protein in dilated cardiomyopathy.

Authors:  K Kaneko; T Kanda; Y Yamauchi; A Hasegawa; T Iwasaki; M Arai; T Suzuki; I Kobayashi; R Nagai
Journal:  Cardiology       Date:  1999       Impact factor: 1.869

5.  Reversible activation of nuclear factor-kappaB in human end-stage heart failure after left ventricular mechanical support.

Authors:  Florian Grabellus; Bodo Levkau; Andrea Sokoll; Hendryk Welp; Christof Schmid; Mario C Deng; Atsushi Takeda; Günter Breithardt; Hideo A Baba
Journal:  Cardiovasc Res       Date:  2002-01       Impact factor: 10.787

6.  Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure.

Authors:  A Deswal; B Bozkurt; Y Seta; S Parilti-Eiswirth; F A Hayes; C Blosch; D L Mann
Journal:  Circulation       Date:  1999-06-29       Impact factor: 29.690

7.  B-cell function in chronic heart failure: antibody response to pneumococcal vaccine.

Authors:  A Doing; D Griffin; J A Jacobson; I J Amber; E Gilbert
Journal:  J Card Fail       Date:  2001-12       Impact factor: 5.712

8.  Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure.

Authors:  Sabine Genth-Zotz; Stephan von Haehling; Aidan P Bolger; Paul R Kalra; Roland Wensel; Andrew J S Coats; Stefan D Anker
Journal:  Am J Cardiol       Date:  2002-12-01       Impact factor: 2.778

9.  Plasma cytokine parameters and mortality in patients with chronic heart failure.

Authors:  M Rauchhaus; W Doehner; D P Francis; C Davos; M Kemp; C Liebenthal; J Niebauer; J Hooper; H D Volk; A J Coats; S D Anker
Journal:  Circulation       Date:  2000-12-19       Impact factor: 29.690

10.  Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure.

Authors:  Aidan P Bolger; Rakesh Sharma; Stephan von Haehling; Wolfram Doehner; Brian Oliver; Mathias Rauchhaus; Andrew J S Coats; Ian M Adcock; Stefan D Anker
Journal:  Am J Cardiol       Date:  2002-08-15       Impact factor: 2.778

View more
  140 in total

1.  Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community.

Authors:  Arduino A Mangoni; Richard J Woodman; Paraskevi Gaganis; Andrew L Gilbert; Kathleen M Knights
Journal:  Br J Clin Pharmacol       Date:  2010-06       Impact factor: 4.335

2.  Statins for heart failure: at the crossroads between cholesterol reduction and pleiotropism?

Authors:  S von Haehling; S D Anker
Journal:  Heart       Date:  2005-01       Impact factor: 5.994

3.  Metabolic syndrome, inflammation, and incident heart failure in the elderly: the cardiovascular health study.

Authors:  Takeki Suzuki; Ronit Katz; Nancy Swords Jenny; Neil A Zakai; Martin M LeWinter; Joshua I Barzilay; Mary Cushman
Journal:  Circ Heart Fail       Date:  2008-09-23       Impact factor: 8.790

Review 4.  A multidimensional sight on cardiac failure: uncovered from structural to molecular level.

Authors:  Vijay Urmaliya; Gustavo Franchelli
Journal:  Heart Fail Rev       Date:  2017-05       Impact factor: 4.214

5.  Cyclic stretch enhances the expression of toll-like receptor 4 gene in cultured cardiomyocytes via p38 MAP kinase and NF-kappaB pathway.

Authors:  Kou-Gi Shyu; Bao-Wei Wang; Chiu-Mei Lin; Hang Chang
Journal:  J Biomed Sci       Date:  2010-03-05       Impact factor: 8.410

6.  Long-Term Weight Gain Associated With High Omentin Levels at Hospital Discharge Improves Prognosis of Patients Following Acute Heart Failure.

Authors:  Rosa M Agra-Bermejo; Rocio Gonzalez-Ferreiro; J Nicolos Lopez-Canoa; Alfonso Varela-Roman; Ines Gomez-Otero; Sonia Eiras; José R González-Juanatey
Journal:  J Cardiovasc Transl Res       Date:  2018-10-23       Impact factor: 4.132

7.  Republished: pathogenesis and diagnosis of myocarditis.

Authors:  Chantal Elamm; Delisa Fairweather; Leslie T Cooper
Journal:  Postgrad Med J       Date:  2012-09       Impact factor: 2.401

8.  Lipopolysaccharide upregulates uPA, MMP-2 and MMP-9 via ERK1/2 signaling in H9c2 cardiomyoblast cells.

Authors:  Yi-Chang Cheng; Li-Mien Chen; Mu-Hsin Chang; Wei-Kung Chen; Fuu-Jen Tsai; Chang-Hai Tsai; Tung-Yuan Lai; Wei-Wen Kuo; Chih-Yang Huang; Chung-Jung Liu
Journal:  Mol Cell Biochem       Date:  2009-01-28       Impact factor: 3.396

Review 9.  Biomarkers in heart failure: a clinical review.

Authors:  J Paul Rocchiccioli; John J V McMurray; Anna F Dominiczak
Journal:  Heart Fail Rev       Date:  2008-12-03       Impact factor: 4.214

10.  Leukocyte redistribution: effects of beta blockers in patients with chronic heart failure.

Authors:  Stephan von Haehling; Joerg C Schefold; Ewa Jankowska; Wolfram Doehner; Jochen Springer; Kristin Strohschein; Sabine Genth-Zotz; Hans-Dieter Volk; Philip Poole-Wilson; Stefan D Anker
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.